Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher (TMO)
NYSE:TMO
TMO Stock Chart & Stats
$579.12
$0.83(0.15%)
At close: 4:00 PM EST
$579.12
$0.83(0.15%)
Day’s Range― - ―
52-Week Range$385.46 - $610.97
Previous CloseN/A
Volume471.20K
Average Volume (3M)1.65M
Market Cap
$217.58B
Enterprise Value$207.75B
Total Cash (Recent Filing)$3.55B
Total Debt (Recent Filing)$35.68B
Price to Earnings (P/E)33.5
Beta0.67
Next Earnings
Jan 29, 2026EPS Estimate
6.45Next Dividend Ex-DateN/A
Dividend Yield0.3%
Share Statistics
EPS (TTM)5.79
Shares Outstanding375,708,070
10 Day Avg. Volume1,808,828
30 Day Avg. Volume1,649,379
Financial Highlights & Ratios
PEG Ratio4.64
Price to Book (P/B)4.01
Price to Sales (P/S)4.63
P/FCF Ratio27.35
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue4.75
Enterprise Value/Gross Profit11.93
Enterprise Value/Ebitda18.33
Forecast
1Y Price Target
$640.30Price Target Upside10.56% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering21
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Earnings GrowthThermo Fisher Scientific reported continuously improved financials for 3Q25, with revenue increasing by 5.0% YoY and adjusted EPS rising by 9.7% YoY.
Market PositioningThermo Fisher is best positioned to benefit from accelerating semiconductor demand, especially with mid-term onshoring dynamics in the US.
Strategic AcquisitionsTMO's acquisition of Clario is a strategic fit that enhances their clinical trial offerings and is expected to be accretive to margins and earnings per share.
Bears Say
Customer PressureUS Academic and Government customers have been under pressure all year and declined.
Growth ChallengesAI is likely to decline year-over-year due to tougher comparisons, resulting in overall 2% fourth-quarter organic growth.
Tariff ImpactTariff assumptions trimmed away some of the previous cushion, affecting the earnings per share guidance.
Thermo Fisher News
TMO FAQ
What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest stock price was $385.46 and its highest was $610.97 in the past 12 months.
What is Thermo Fisher’s market cap?
Thermo Fisher’s market cap is $217.58B.
When is Thermo Fisher’s upcoming earnings report date?
Thermo Fisher’s upcoming earnings report date is Jan 29, 2026 which is in 33 days.
How were Thermo Fisher’s earnings last quarter?
Thermo Fisher released its earnings results on Oct 22, 2025. The company reported $5.79 earnings per share for the quarter, beating the consensus estimate of $5.497 by $0.293.
Is Thermo Fisher overvalued?
According to Wall Street analysts Thermo Fisher’s price is currently Undervalued.
Does Thermo Fisher pay dividends?
Thermo Fisher pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 0.3%. See more information on Thermo Fisher dividends here
What is Thermo Fisher’s EPS estimate?
Thermo Fisher’s EPS estimate is 6.45.
How many shares outstanding does Thermo Fisher have?
Thermo Fisher has 375,708,070 shares outstanding.
What happened to Thermo Fisher’s price movement after its last earnings report?
Thermo Fisher reported an EPS of $5.79 in its last earnings report, beating expectations of $5.497. Following the earnings report the stock price went up 1.65%.
Which hedge fund is a major shareholder of Thermo Fisher?
Currently, no hedge funds are holding shares in TMO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Thermo Fisher Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$640.30 (10.56% Upside)
$640.30 (10.56% Upside)
Blogger Sentiment
Bullish
TMO Sentiment 73%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 920.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $57.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.86%
12-Months-Change
Fundamentals
Return on Equity
13.14%
Trailing 12-Months
Asset Growth
2.65%
Trailing 12-Months
Company Description
Thermo Fisher
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TMO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, growth in key segments, and significant strategic initiatives, including collaborations and acquisitions. However, challenges in the diagnostics sector, particularly in China, and pressures in academic and government sectors were noted.View all TMO earnings summariesTMO Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
TMO Stock 12 Month Forecast
Average Price Target
$640.30
▲(10.56% Upside)
Technical Analysis
Ownership Overview
0.13% Insiders
23.69% Mutual Funds
27.43% Other Institutional Investors
29.47% Public Companies and Individual Investors